Drug
Sitagliptin-Metformin
Sitagliptin-Metformin is a pharmaceutical drug with 5 clinical trials. Historical success rate of 100.0%.
Total Trials
5
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 4 completed trials
Completion Rate
100%(4/4)
Active Trials
0(0%)
Results Posted
75%(3 trials)
Phase Distribution
Ph phase_1
1
20%
Ph phase_3
1
20%
Ph phase_4
2
40%
Phase Distribution
1
Early Stage
0
Mid Stage
3
Late Stage
Phase Distribution4 total trials
Phase 1Safety & dosage
1(25.0%)
Phase 3Large-scale testing
1(25.0%)
Phase 4Post-market surveillance
2(50.0%)
Highest Phase Reached
Phase 4Trial Status & Enrollment
Completion Rate
100.0%
4 of 4 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
0
trials recruiting
Total Trials
5
all time
Status Distribution
Completed(4)
Other(1)
Detailed Status
Completed4
unknown1
Development Timeline
Analytics
Development Status
Total Trials
5
Active
0
Success Rate
100.0%
Most Advanced
Phase 4
Trials by Phase
Phase 11 (25.0%)
Phase 31 (25.0%)
Phase 42 (50.0%)
Trials by Status
completed480%
unknown120%
Recent Activity
0 active trials
Showing 5 of 5
completedphase_4
Effects of Empagliflozin-Metformin, Sitagliptin-Metformin, and Metformin on Adipokines in Type 2 Diabetes
NCT07531108
completedphase_3
Remission Evaluation of a Metabolic Intervention in Type 2 Diabetes With Sitagliptin (REMIT-Sita)
NCT02623998
unknownphase_1
Comparing the Effect of Sitagliptin/Metformin and Metformin in PCOS Patients
NCT04268563
completedphase_4
Sitagliptin + Metformin Compared to Metformin Monotherapy and Placebo in Women With a Recent GDM
NCT01856907
completed
Sitagliptin/Metformin (JANUMET) Re-examination Study (0431A-182)
NCT01065766
Clinical Trials (5)
Showing 5 of 5 trials
NCT07531108Phase 4
Effects of Empagliflozin-Metformin, Sitagliptin-Metformin, and Metformin on Adipokines in Type 2 Diabetes
NCT02623998Phase 3
Remission Evaluation of a Metabolic Intervention in Type 2 Diabetes With Sitagliptin (REMIT-Sita)
NCT04268563Phase 1
Comparing the Effect of Sitagliptin/Metformin and Metformin in PCOS Patients
NCT01856907Phase 4
Sitagliptin + Metformin Compared to Metformin Monotherapy and Placebo in Women With a Recent GDM
NCT01065766
Sitagliptin/Metformin (JANUMET) Re-examination Study (0431A-182)
All 5 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 5